Skip to navigation
A A A

ASTON/M.D. Sass Enhanced Equity Fund

 NI
CUSIP00080Y75100080Y694
TickerAMBEXAMDSX
Share Class Inception1/15/20083/3/2010
Gross Exp Ratio (%)1.371.12
Net Exp Ratio (%)1.361.11
30 Day Yield (11/30/11) 1.76 2.01
NAV8.908.91
NAV Change 1.02 1.14
Benchmarks S&P 500/Citicorp Broad 50 Index
S&P 500 Index
Morningstar Category Large Blend

Overall Morningstar Rating

ASTON/M.D. Sass Enhanced Equity Fund  Shares received a Morningstar rating.

Among 73 Long-Short Equity funds derived from a weighted average of the Fund’s 3-, 5- and 10-year risk-adjusted returns as of 12/31/11.

Portfolio Manager

Ronald L.  Altman

Ronald L. Altman

Mr. Altman joined M.D. Sass in June of 2009 as a portfolio manager. Prior to M.D. Sass, he was a partner and portfolio manager at MB Investment Partners, Inc. From 1999 to 2005, Mr. Altman was a Senior Managing Director and Director of Research at Victory SBSF. Mr. Altman has more than 40 years of experience in the investment research and money management business in various positions.

Objective

The ASTON/M.D. Sass Enhanced Equity Fund seeks total return through a combination of a high level of current income and capital appreciation.

If you are an investment professional, login or register here for access to Aston’s research content. Discover the unique qualities that differentiate our Subadvisers at both the firm and strategy levels.  

Risk Considerations

By selling covered call options, the Fund limits its opportunity to profit from an increase in the price of the underlying stock above the exercise price, but continues to bear the risk of a decline in the stock. A liquid market may not exist for options held by the Fund. If the Fund is not able to close out an options transaction, it will not be able to sell the underlying security until the option expires or is exercised. While the Fund receives premiums for writing the call options, the price it realizes from the exercise of an option could be substantially below a stock's current market price. Premiums from the Fund's sale of call options typically will result in short-term capital gain taxes, making it ill suited for investors seeking a tax efficient investment.

Fund Stats (as of 12/31/11) N SharesI Shares
Origin Of Information ThomsonThomson
Sales Load NoneNone
Total Net Assets (2/3/12)$54,838,513.53$72,887,377.67
Turnover 82%82%
Minimum Investment 2,5001,000,000
Alpha (3 yr.) 3.36N/A
Beta (3 yr.) 0.70N/A
R-Squared (3 yr.) 0.80N/A
Standard Dev (3 yr.) 14.82N/A
Sharpe Ratio (3 yr.) 0.26N/A
Current Wtd Average P/E (trailing) 12.5412.54
Current Wtd Average P/B (trailing) 1.531.53
Median Mkt Cap ($Mil) 25,72425,724
Average Wtd Coupon N/AN/A
Effective Maturity N/AN/A
Sector Breakdown (as of 12/31/11)
Information Technology
18.42%
Utilities
17.59%
Industrials
17.40%
Financials
12.60%
Consumer Discretionary
12.51%
Health Care
11.41%
Consumer Staples
8.99%
Telecommunication Services
3.37%
Cash Equivalents & Other
-2.29%
Top Ten Holdings (as of 12/31/11)
CompanyTickerCUSIPNumber of SharesMarket Value% of Net Assets
EXELON CORP EXC 30161N101 93,000 $4,033,410.00 3.78%
ENTERGY CORP ETR 29364G103 55,000 $4,017,750.00 3.76%
PUBLIC SERVICE ENTERPRISE GP PEG 744573106 120,000 $3,961,200.00 3.71%
GENERAL ELECTRIC CO GE 369604103 220,000 $3,940,200.00 3.69%
CISCO SYSTEMS INC CSCO 17275R102 215,000 $3,887,200.00 3.64%
ELI LILLY & CO LLY 532457108 90,000 $3,740,400.00 3.50%
NEXTERA ENERGY INC NEE 65339F101 61,000 $3,713,680.00 3.48%
MEDTRONIC INC MDT 585055106 95,000 $3,633,750.00 3.40%
AT&T INC T 00206R102 120,000 $3,628,800.00 3.40%
METLIFE INC MET 59156R108 115,000 $3,585,700.00 3.36%
Past performance does not guarantee future results. Investment return and principal value of mutual funds will vary with market conditions, so that shares, when redeemed, may be worth more or less than their original cost.

As the fund is actively managed, the securities as presented may not represent the current or future composition of the portfolio.

Designed and created by DDM Marketing & Communications.